RATIONALE: Chronic obstructive pulmonary disease (COPD) is a heterogeneous disorder associated with systemic manifestations that contribute to its morbidity and mortality. Recent work suggests that biomarker signatures in the blood may be useful in evaluating COPD phenotypes and may provide insight into the pathophysiology of systemic manifestations. Adiponectin, primarily produced by fat cells, has been implicated in the pathophysiology of emphysema. OBJECTIVES: To investigate the association of adiponectin with clinical and radiologic COPD phenotypes. METHODS: Adiponectin levels were determined in 633 individuals, including 432 individuals with COPD from a cohort of former or current smokers enrolled in the COPDGene study. Univariate and multiple regression analysis were used to examine the association of adiponectin with clinical and physiologic data together with quantitative high-resolution computed tomography parameters. MEASUREMENTS AND MAIN RESULTS: Multiple regression analysis confirmed that higher plasma adiponectin levels were independently associated with emphysema, decreasing body mass index, female sex, older age, and lower percentage change in prebronchodilator/post-bronchodilator FEV1. CONCLUSIONS: The association between plasma adiponectin and computed tomography-assessed emphysema suggests a contribution of adiponectin to the development of emphysema and highlights a role for metabolic derangements in the pathophysiology of emphysema.
RATIONALE: Chronic obstructive pulmonary disease (COPD) is a heterogeneous disorder associated with systemic manifestations that contribute to its morbidity and mortality. Recent work suggests that biomarker signatures in the blood may be useful in evaluating COPD phenotypes and may provide insight into the pathophysiology of systemic manifestations. Adiponectin, primarily produced by fat cells, has been implicated in the pathophysiology of emphysema. OBJECTIVES: To investigate the association of adiponectin with clinical and radiologic COPD phenotypes. METHODS:Adiponectin levels were determined in 633 individuals, including 432 individuals with COPD from a cohort of former or current smokers enrolled in the COPDGene study. Univariate and multiple regression analysis were used to examine the association of adiponectin with clinical and physiologic data together with quantitative high-resolution computed tomography parameters. MEASUREMENTS AND MAIN RESULTS: Multiple regression analysis confirmed that higher plasma adiponectin levels were independently associated with emphysema, decreasing body mass index, female sex, older age, and lower percentage change in prebronchodilator/post-bronchodilator FEV1. CONCLUSIONS: The association between plasma adiponectin and computed tomography-assessed emphysema suggests a contribution of adiponectin to the development of emphysema and highlights a role for metabolic derangements in the pathophysiology of emphysema.
Authors: Harvey O Coxson; Ida H T Chan; John R Mayo; Julia Hlynsky; Yasutaka Nakano; C Laird Birmingham Journal: Am J Respir Crit Care Med Date: 2004-07-15 Impact factor: 21.405
Authors: Jørgen Vestbo; Suzanne S Hurd; Alvar G Agustí; Paul W Jones; Claus Vogelmeier; Antonio Anzueto; Peter J Barnes; Leonardo M Fabbri; Fernando J Martinez; Masaharu Nishimura; Robert A Stockley; Don D Sin; Roberto Rodriguez-Roisin Journal: Am J Respir Crit Care Med Date: 2012-08-09 Impact factor: 21.405
Authors: Anna M Wolf; Dominik Wolf; Holger Rumpold; Barbara Enrich; Herbert Tilg Journal: Biochem Biophys Res Commun Date: 2004-10-15 Impact factor: 3.575
Authors: Meghan C Wulster-Radcliffe; Kolapo M Ajuwon; Jiazhen Wang; John A Christian; Michael E Spurlock Journal: Biochem Biophys Res Commun Date: 2004-04-09 Impact factor: 3.575
Authors: Elizabeth A Regan; Craig P Hersh; Peter J Castaldi; Dawn L DeMeo; Edwin K Silverman; James D Crapo; Russell P Bowler Journal: Am J Respir Cell Mol Biol Date: 2019-08 Impact factor: 6.914
Authors: Janet G Shaw; Annalicia Vaughan; Annette G Dent; Phoebe E O'Hare; Felicia Goh; Rayleen V Bowman; Kwun M Fong; Ian A Yang Journal: J Thorac Dis Date: 2014-11 Impact factor: 2.895
Authors: Russell P Bowler; Sean Jacobson; Charmion Cruickshank; Grant J Hughes; Charlotte Siska; Daniel S Ory; Irina Petrache; Jean E Schaffer; Nichole Reisdorph; Katerina Kechris Journal: Am J Respir Crit Care Med Date: 2015-02-01 Impact factor: 21.405
Authors: Jason D Keene; Sean Jacobson; Katerina Kechris; Gregory L Kinney; Marilyn G Foreman; Claire M Doerschuk; Barry J Make; Jeffrey L Curtis; Stephen I Rennard; R Graham Barr; Eugene R Bleecker; Richard E Kanner; Eric C Kleerup; Nadia N Hansel; Prescott G Woodruff; MeiLan K Han; Robert Paine; Fernando J Martinez; Russell P Bowler; Wanda K O'Neal Journal: Am J Respir Crit Care Med Date: 2017-02-15 Impact factor: 21.405
Authors: Young Ju Suh; Merry-Lynn N McDonald; George R Washko; Brendan J Carolan; Russell P Bowler; David A Lynch; Gregory L Kinney; Jessica M Bon; Michael H Cho; James D Crapo; Elizabeth A Regan Journal: Chronic Obstr Pulm Dis Date: 2018-04-01
Authors: Barbara Jane George; David M Reif; Jane E Gallagher; ClarLynda R Williams-DeVane; Brooke L Heidenfelder; Edward E Hudgens; Wendell Jones; Lucas Neas; Elaine A Cohen Hubal; Stephen W Edwards Journal: PLoS One Date: 2015-02-02 Impact factor: 3.240